In particular, various studies report that activation of HCA2 reduces inflammation in atherosclerosis (36), diabetes mellitus (25), diabetic retinopathy (31), neurodegenerative diseases (37, 38), sepsis (39), mammary cancer (40) and pancreatitis (41). This evidence concerns the gene HCAR2 and breast cancer.